Saudi Pharmaceutical Industries and Medical Appliances Future Growth
Future criteria checks 4/6
Saudi Pharmaceutical Industries and Medical Appliances is forecast to grow earnings and revenue by 33.5% and 10.1% per annum respectively. EPS is expected to grow by 31.5% per annum. Return on equity is forecast to be 11.8% in 3 years.
Key information
33.5%
Earnings growth rate
31.5%
EPS growth rate
Pharmaceuticals earnings growth | 16.3% |
Revenue growth rate | 10.1% |
Future return on equity | 11.8% |
Analyst coverage | Low |
Last updated | 03 Dec 2024 |
Recent future growth updates
Recent updates
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Solid Earnings May Rest On Weak Foundations
Nov 24Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump
Sep 05Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing
Mar 21Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?
Jun 26Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?
Mar 14Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price
Aug 02Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60
May 19One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates
May 12A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Feb 20Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 18Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?
Mar 30Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?
Feb 23What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition
Jan 19Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?
Dec 16Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,153 | 185 | 192 | 183 | 5 |
12/31/2025 | 1,958 | 145 | 146 | 163 | 5 |
12/31/2024 | 1,726 | 114 | 39 | -73 | 2 |
9/30/2024 | 1,628 | 23 | -266 | -156 | N/A |
6/30/2024 | 1,562 | -18 | -60 | 78 | N/A |
3/31/2024 | 1,597 | -40 | 35 | 152 | N/A |
12/31/2023 | 1,653 | -20 | -70 | 48 | N/A |
9/30/2023 | 1,686 | -76 | -30 | 52 | N/A |
6/30/2023 | 1,662 | -78 | -60 | 7 | N/A |
3/31/2023 | 1,564 | -142 | -213 | -136 | N/A |
12/31/2022 | 1,422 | -152 | -178 | -99 | N/A |
9/30/2022 | 1,425 | -94 | -195 | -109 | N/A |
6/30/2022 | 1,379 | -42 | -229 | -136 | N/A |
3/31/2022 | 1,394 | 38 | -10 | 73 | N/A |
12/31/2021 | 1,460 | 30 | 9 | 87 | N/A |
9/30/2021 | 1,471 | 57 | -102 | 18 | N/A |
6/30/2021 | 1,532 | 117 | -145 | -24 | N/A |
3/31/2021 | 1,534 | 110 | -172 | -23 | N/A |
12/31/2020 | 1,555 | 130 | -165 | 10 | N/A |
9/30/2020 | 1,521 | -114 | 44 | 278 | N/A |
6/30/2020 | 1,491 | -153 | 241 | 505 | N/A |
3/31/2020 | 1,518 | -365 | -37 | 275 | N/A |
12/31/2019 | 1,487 | -434 | 18 | 352 | N/A |
9/30/2019 | 1,743 | -163 | -164 | 138 | N/A |
6/30/2019 | 1,626 | -204 | -461 | -165 | N/A |
3/31/2019 | 1,566 | 6 | -271 | 10 | N/A |
12/31/2018 | 1,503 | 74 | -355 | -74 | N/A |
9/30/2018 | 1,313 | 66 | -280 | -42 | N/A |
6/30/2018 | 1,366 | 61 | N/A | 25 | N/A |
3/31/2018 | 1,375 | 85 | N/A | 103 | N/A |
12/31/2017 | 1,386 | 139 | N/A | 155 | N/A |
9/30/2017 | 1,315 | 274 | N/A | 205 | N/A |
6/30/2017 | 1,295 | 296 | N/A | 118 | N/A |
3/31/2017 | 1,329 | 289 | N/A | -21 | N/A |
12/31/2016 | 1,259 | 277 | N/A | -94 | N/A |
9/30/2016 | 1,448 | 124 | N/A | -281 | N/A |
6/30/2016 | 1,499 | 149 | N/A | -134 | N/A |
3/31/2016 | 1,595 | 347 | N/A | -53 | N/A |
12/31/2015 | 1,705 | 357 | N/A | -38 | N/A |
9/30/2015 | 1,604 | 457 | N/A | 115 | N/A |
6/30/2015 | 1,562 | 465 | N/A | 44 | N/A |
3/31/2015 | 1,500 | 325 | N/A | 12 | N/A |
12/31/2014 | 1,470 | 317 | N/A | 43 | N/A |
9/30/2014 | 1,424 | 283 | N/A | -94 | N/A |
6/30/2014 | 1,381 | 279 | N/A | -79 | N/A |
3/31/2014 | 1,351 | 295 | N/A | 79 | N/A |
12/31/2013 | 1,311 | 267 | N/A | 54 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2070's forecast earnings growth (33.5% per year) is above the savings rate (14.7%).
Earnings vs Market: 2070's earnings (33.5% per year) are forecast to grow faster than the SA market (6.1% per year).
High Growth Earnings: 2070's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2070's revenue (10.1% per year) is forecast to grow faster than the SA market (-0.5% per year).
High Growth Revenue: 2070's revenue (10.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2070's Return on Equity is forecast to be low in 3 years time (11.8%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 05:18 |
End of Day Share Price | 2024/12/25 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Saudi Pharmaceutical Industries and Medical Appliances Corporation is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Abdullah Alawi | Aljazira Capital Company |
Madhu Appissa | Al Rajhi Capital |
Aleksandar Stojanovski | Deutsche Bank |